Tikun Olam-Cannbit Pharmaceuticals Ltd

Tel Aviv Stock Exchange TKUN.TA

Tikun Olam-Cannbit Pharmaceuticals Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2023: -190.06%

Tikun Olam-Cannbit Pharmaceuticals Ltd Return on Capital Employed (ROCE) is -190.06% for the year ending December 31, 2023, a -420.04% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Tikun Olam-Cannbit Pharmaceuticals Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2022 was -36.55%, a -86.16% change year over year.
  • Tikun Olam-Cannbit Pharmaceuticals Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2021 was -19.63%, a 2.29% change year over year.
  • Tikun Olam-Cannbit Pharmaceuticals Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2020 was -20.09%, a -167.89% change year over year.
  • Tikun Olam-Cannbit Pharmaceuticals Ltd Return on Capital Employed (ROCE) for the year ending December 31, 2019 was -7.50%.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
SV Wall Street
Tel Aviv Stock Exchange: TKUN.TA

Tikun Olam-Cannbit Pharmaceuticals Ltd

CEO Mr. Ronen Elad
IPO Date Aug. 12, 2002
Location Israel
Headquarters Hitad 2
Employees 50
Sector Health Care
Industries
Pharmaceuticals
Description

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the research, development, cultivation, manufacture, and distribution of medical cannabis and related products. It also provides training and patient care services. The company is based in Nof Hagalil, Israel.

StockViz Staff

January 30, 2025

Any question? Send us an email